Re: Kaplan 100 Cases Of Ethics Pdf Download
Rocki Stenger
Randy Tietjen is a partner in the Business Litigation Group. In his thirty years as a lawyer, he has represented individuals and a variety of businesses and other organizations in an array of litigation matters, involving securities, antitrust laws, intellectual property, minority-shareholder claims, contracts, ERISA, fiduciary duties, trade secrets, and fraud claims, among other business-litigation torts. He has had clients in many areas of commerce, including banking, food and beverage, manufacturing, telecommunications, and healthcare. Randy has appeared in many federal and state trial courts and courts of appeal and he has handled international and domestic arbitrations and mediation. His practice also includes matters involving questions of professional responsibility for law firms and lawyers. For the past ten years he has served as the Ethics Partner for Robins Kaplan LLP.
Over the course of his career, Randy has devoted, on average, nearly two hundred hours a year to pro-bono matters, including civil-liberties cases and other matters raising constitutional issues. For many years, he organized and supervised lawyers at the firm who tried cases and argued appeals on behalf of (non-lawyer) guardians ad litem for children in the juvenile courts, usually involving parents who were potentially unable or unfit to care for their children. The lawyers tried cases in more than twenty counties in mostly outstate Minnesota, logging more than 25,000 pro-bono hours on behalf of children, for which the Minnesota Supreme Court gave an award to the law firm for recognition of its contributions to the welfare of so many children.
Electronic health records, data sharing, big data, data mining, and secondary use are enabling exciting opportunities for improving health and healthcare while also exacerbating privacy concerns. Two court cases about selling prescription data, the Sorrell case in the U.S. and the Source case in the U.K., raise questions of what constitutes "privacy" and "public interest"; they present an opportunity for ethical analysis of data privacy, commodifying data for sale and ownership, combining public and private data, data for research, and transparency and consent. These interwoven issues involve discussion of big data benefits and harms and touch on common dualities of the individual versus the aggregate or the public interest, research (or, more broadly, innovation) versus privacy, individual versus institutional power, identification versus identity and authentication, and virtual versus real individuals and contextualized information. Transparency, flexibility, and accountability are needed for assessing appropriate, judicious, and ethical data uses and users, as some are more compatible with societal norms and values than others.
Although many companies have well-developed procedures and practices for reporting information to their boards regarding their compliance and ethics programs, training members of the board is an area that organizations continue to grapple with. Indeed,...
It even has info about that 1 question on UWSA1 about seizure and driving ability (or was it NBME 18 I forgot lol). So I thought that was the signal it might have *almost* everything ethics have to offer us on USMLE...
Plaintiff lists five specific and distinct statements contained in the emails as the defamatory statements: (1) a statement that the suspension of Rabbi Kaplan from the CCAR "prohibited him from working as a Rabbi;" (2) a statement that "we [the CCAR] are deeply disturbed that he [plaintiff] continues to present himself as a rabbi available for hire in the community;" (3) a statement that Rabbi Kaplan's former congregation had been notified "about the reasons for his expulsion, including the Ethics Code provisions that he violated;" (4) a statement that "[W]e [the CCAR] take ethical misconduct of any kind extremely seriously and we are pained to see any misconduct by a rabbi in the Jewish community. We are fully committed to the sanctity, safety and security of our communities and the people our rabbis [*3]serve, as well as the importance of rabbinic integrity;" and (5) a statement that "we [the CCAR] remain committed to the sanctity and safety of our communities and individuals. We are pained by any abuse or misconduct and we have an ethics system in place to address ethical misconduct by a CCAR rabbi that harms any individual, congregation or organization."
The third statement relating to the notification of his former congregation, is not defamation as the statement is indisputably true. Plaintiff does not argue that the statement is false but rather argues that "when viewed in context with the other statements made by Defendants, [the] statement must be construed to mean that Rabbi Kaplan was expelled for [*5]violating the CCAR Ethics Code." First, a plain reading of the sentence says that the congregation was informed of the reasons, including the CCAR Ethics Codes plaintiff violated. In other words, the congregation was informed of the reasons for the expulsion, not limited to CCAR Ethics violations. Second, the statement that plaintiff was expelled for violation of the Ethics Code, is true. It is undisputed that plaintiff was suspended and was offered a rehabilitation process. Rather than proceed with the rehabilitation process, plaintiff first appealed the suspension and later resigned from CCAR. Under the CCAR Ethics Code Section VI.E.2 "a rabbi who resigns from the CCAR prior to, during or after the adjudicatory process will be regarded as expelled (d) The sanction of expulsion is reserved for the gravest offenses, repeated violations, failure to comply with conditions of censure or with conditions of suspension, or willful violation of the section entitled "failure to cooperate." Here, plaintiff resigned during or after the adjudicatory process[FN1] and was thus deemed expelled for willful violation for failure to cooperate or failure to comply with terms of suspension. In fact, plaintiff's motion papers state "[U]nder the CCAR ethics policy, this resignation had the effect of an expulsion from the CCAR" (Plaintiffs Opposition 10). Finally, as with the previous two alleged defamatory statements, this statement must also be read in conjunction with the entire email and in the proper context. CCAR, responding to the Forward's clarifying questions as to why plaintiff was expelled, clearly explained the reasons, procedure and sequence of events leading to plaintiff's expulsion, including that "rather than comply with the terms of suspension, Kaplan chose to submit a letter of resignation from the CCAR. The CCAR responded by formally expelling him, as mandated in CCAR's Ethics Code." As the statement was true, no defamation lies (Silverman 35 AD3d at 12).
In 2018, Justice Clarence Thomas attended this fundraiser, one of several he allegedly attended over the years. That's according to another new investigation by ProPublica. Like their previous reports, this raises serious questions over Justice Thomas' undisclosed connections to powerful people who have brought cases before the Supreme Court, including one of the most watched cases in the court's upcoming term.
The IAESB Ethics Education Framework (EEF) shown above is designed to provide a structure for the development of ethical education. It recognises that ethics education is actually a lifelong process and will continue through the career of an accountant or any other professional. The framework establishes a four-stage learning continuum which professionals will generally move through during their careers.
(3)An identification of the norms, principles, and values related to the case. This involves placing the decision in its social, ethical, and, in some cases, professional behaviour context. In this last context, professional codes of ethics or the social expectations of the profession are taken to be the norms, principles, and values. For example, if stock market rules are involved in the decision, then these will be a relevant factor to consider in this step.
However, where the approach to moral dilemmas tends to the 'principles-based' then reframing moral decisions is inappropriate. There are no rules to follow, therefore ethics must be discussed and actions justified based on sound ethical judgement.
All ACA members are required to abide by the ACA Code of Ethics, and 21 state licensing boards use it as the basis for adjudicating complaints of ethical violations. As a service to members, Counseling Today is publishing a monthly column focusing on new aspects of the ACA Code of Ethics (the ethics code is also available online at www.counseling.org/ethics). ACA Chief Professional Officer David Kaplan conducted the following interview with Vilia Tarvydas and Christine Moll, two members of the ACA Ethical Code Revision Task Force.
Vilia Tarvydas: The ACA Ethics Committee had been periodically receiving inquiries about end-of-life care. The number of inquiries grew with the implementation of the Oregon assisted suicide law and some prominent cases, such as the Terri Schiavo right-to-die case in Florida. It became obvious to us that our code was not giving sufficient guidance to counselors.
Prior to coming to NYU Langone, Dr. Caplan was the Sidney D. Caplan Professor of Bioethics at the University of Pennsylvania Perelman School of Medicine in Philadelphia, where he created the Center for Bioethics and the Department of Medical Ethics. He has also taught at the University of Minnesota, where he founded the Center for Biomedical Ethics; the University of Pittsburgh; and Columbia University. He received his PhD from Columbia University.
Dr. Caplan is a regular commentator on bioethics and health care issues for WebMD/Medscape, WGBH radio in Boston, WOR radio in New York City, and KNX-CBS in Los Angeles. He appears frequently as a guest and commentator on various other national and international media outlets.
During the COVID-19 pandemic, he co-directed an advisory group on sports and recreation for the U.S. Conference of Mayors, created a working group on coronavirus vaccine challenge studies, developed an ethical framework for distributing drugs and vaccines for J&J, and helped develop rationing policies for NYU Langone Health and many other health systems. He was a member of the WHO advisory committee on COVID-19, ethics, and experimental drugs/vaccines, and he helped set policy for WIRB/WCG for research studies. He was an adviser to Moderna, Inc., and Accenture. He continues to serve on the NCAA Sports and COVID-19 Committee.
aa06259810